# Bodal Chemicals share price today (Bodal Chemicals Ltd, NSE: BODALCHEM)

> Bodal Chemicals share price today: ₹178.62 at the NSE close on 3 November 2026, up 191.2% in a year. Bodal Chemicals (NSE: BODALCHEM) is worth ₹2,243 crore, trades at a P/E of 32.7 and has closed between ₹43.45 and ₹201.80 over the past 52 weeks. > Bodal Chemicals Ltd's share price has risen faster than its earnings: +191.2% in a year, against +158.5% for earnings per share. BODALCHEM · Dyes & Pigments · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/bodal-chemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹178.62 (+191.2% in a year)
- P/E: 32.7× (higher than 83% of the last 11 years)
- Revenue (Jun 2026): ₹709 Cr (+56.2% on a year ago)
- Profit (Jun 2026): ₹30.0 Cr (+200.0% on a year ago)
- Operating margin: 10.0% (flat on a year ago)
- ROCE: 6%, FY26
- ROIC: 9.4%, against a 12.0% cost of capital: −2.6 points

The main question: the share price moved +191.2% in a year while yearly earnings per share moved +158.5%. The difference came from the market paying a higher multiple. ## What is the Bodal Chemicals share price today? Bodal Chemicals Ltd's share price was ₹178.62 at the close on 3 November 2026. It has been rising for 26 weeks. That is 76.5% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹43 and ₹202, and at that close it sat 85% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 13 weeks in a row. Over the last 11 years the share price moved +202% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Bodal Chemicals this quarter? Two changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare) and highest quarterly revenue in 15 quarters. 1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹709 crore, +56.2% on a year earlier. 2. Highest quarterly revenue in 15 quarters Revenue of ₹709 crore in the June 2026 quarter is the highest of the last 15 quarters. ## What are Bodal Chemicals' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Bodal Chemicals reported revenue of ₹709 crore, up 56.2% from ₹454 crore a year earlier, and a profit of ₹30.0 crore, up 200.0% from ₹10.0 crore. ### Bodal Chemicals results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹709 crore | ₹454 crore | +56.2% |
| Profit | ₹30.0 crore | ₹10.0 crore | +200.0% |
| Earnings per share | ₹2.41 | ₹0.76 | +217.1% |
| Operating margin | 10.0% | 10.0% | 0.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 12 August 2025, about April to June 2025; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Bodal Chemicals share price history? Bodal Chemicals closed at ₹178.62 on 3 November 2026, up 191.2% from ₹61.33 a year earlier (31 October 2025) and up 36.1% over five years. Its highest weekly close since March 2016 was ₹201.80 on 25 September 2026. ### Bodal Chemicals share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹141.25 | +26.5% |
| 1 month ago · 1 Oct 2026 | ₹192.00 | −7.0% |
| 6 months ago · 30 Apr 2026 | ₹68.06 | +162.4% |
| 1 year ago · 31 Oct 2025 | ₹61.33 | +191.2% |
| 3 years ago · 3 Nov 2023 | ₹76.40 | +133.8% |
| 5 years ago · 4 Nov 2021 | ₹131.20 | +36.1% |
| 10 years ago · 4 Nov 2016 | ₹134.50 | +32.8% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹59.05 | +202.5% |
| Highest weekly close since March 2016, also the 52-week high · 25 Sep 2026 | ₹201.80 | −11.5% |
| Lowest weekly close since March 2016 · 27 Mar 2020 | ₹39.80 | +348.8% |
| 52-week low (weekly close) · 13 Mar 2026 | ₹43.45 | +311.1% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (564 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Bodal Chemicals? 3 Nov 2026: Bodal Chemicals closed at ₹178.62, up 26.5% on the week and down 7.0% on the month. Results for April to June 2026: Revenue up 56.2% and profit up 200.0% on a year earlier. ### Earlier

- 12 Aug 2025: Bodal Chemicals held its results call for April to June 2025. ## What dividend does Bodal Chemicals pay? Bodal Chemicals paid no dividend in the 12 months to 4 November 2026. The last was a dividend of ₹0.10 a share, ex-date 22 September 2023. ### Bodal Chemicals dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 22 Sep 2023 | ₹0.10 | Dividend |
| 22 Sep 2022 | ₹0.80 | Dividend |
| 16 Sep 2021 | ₹0.80 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 3 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Bodal Chemicals Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 8 of its last 13 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Bodal Chemicals management say on the latest results call? On the call for April to June 2025, held on 12 August 2025, Bodal Chemicals' management spoke about the quarter; the main points are below. Source: [the call transcript](https://files.tijorifinance.com/insight/india/2653/Conference Call/CC-Jun25.pdf). (From the call for April to June 2025, 12 August 2025. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## Which stock lists is Bodal Chemicals on? Bodal Chemicals is not on any of our India lists this week. ## Is Bodal Chemicals profitable? Bodal Chemicals Ltd earned ₹30.0 Cr of net profit in the Jun 2026 quarter, +200.0% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹48.0 Cr. Over 10 years profit has grown −5.7% a year on average. That is 4.2% of the quarter's revenue. The same quarter a year earlier earned ₹10.0 Cr. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹48.0 Cr (+166.7% on the year before). Why profit moved: revenue changed +56.2% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +76.2% and revenue +27.3%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Bodal Chemicals make, and is it growing? Bodal Chemicals Ltd reported ₹709 Cr of revenue in the Jun 2026 quarter, +56.2% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 10 years it has grown 8.3% a year on average. The last full year, FY26, came in at ₹2,012 Cr. The last four reported quarters add to ₹2,267 Cr. FY26 revenue was ₹2,012 Cr, +15.1% on the year before. Recent pace: the last four quarters grew +27.3% on average, against 8.3% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +27.6%, against +23.6% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +134.5%, against +376.1% a year (rolling over). ## How much of every ₹100 of sales does Bodal Chemicals keep? Bodal Chemicals Ltd's operating margin was 10.0% in the Jun 2026 quarter, about the same as the same quarter a year ago. Across 13 years it has been between 7.0% and 20.0%. The latest quarter is within that range. In the latest quarter it moved +0.0 percentage points on the same quarter a year ago. Why the margin moved: operating margin changed −0.8 percentage points on the year while gross margin changed −7.8 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Bodal Chemicals' profit turning into cash? Over the last 3 years, 686% of Bodal Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹176 Cr of operating cash against ₹48.0 Cr of profit. After ₹14.0 Cr of spending on assets, ₹162 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 686% of profit came in as cash: the cash cycle got 73 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: the bigger use of cash is spending on new assets, at 1.7× depreciation over three years. The next section checks what that spending is building. ## Where does Bodal Chemicals' cash go? Bodal Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 105 days in FY26, down from 178 days in FY21. It spent ₹345 Cr on assets over the last 3 years. Customers take 80 days to pay, and stock sits for 106 days on average. At FY26 sales of ₹2,012 Cr, each day of that cycle ties up about ₹5.5 Cr, so roughly ₹579 Cr is tied up in the business at any time. FY26: customers took 80 days to pay and stock sat for 106 days, about 3.5 months of sales sitting as stock, for a full cycle of 105 days, shorter than FY21's 178. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 106 days. Customers pay about 80 days after that. Suppliers are paid at 81 days. Together that makes the 105-day cycle. Spending on assets: ₹345 Cr over the last 3 years, against ₹199 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹67.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Bodal Chemicals' P/E ratio, and how does it compare with its own history? Bodal Chemicals Ltd's P/E is 32.7×, near the high end of its own history: higher than 83% of past readings. Its usual P/E (the middle reading) is 15.9×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +158.5% while the price moved +191.2%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +6.4% a year; about −8.4% a year came from earnings growth and about +14.8 percentage points from the multiple (the market paying more); over 10 years the price moved +2.9% a year; about −3.1% a year came from earnings growth and about +6.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Bodal Chemicals business getting better or worse? Bodal Chemicals Ltd's business is giving mixed signals. Growth is slowing from a very fast pace: profit growth has eased from +866.7% at its peak to +134.5%, but the business is still expanding, with ROCE steady at 4.4%. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Bodal Chemicals earn on its capital? Bodal Chemicals Ltd earned a ROCE of 6% in FY26. That is up from a low of 3% in FY24. Its return on capital used (ROIC) is 2.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 2.4% net margin and 0.86× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 2.4% net margin × 0.86× asset turnover × 2.02× leverage (assets divided by equity) ≈ 4.2% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 9.4% − 12.0% = −2.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 9.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 4.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Bodal Chemicals have too much debt? Bodal Chemicals Ltd has total debt of ₹813 Cr against shareholder equity of ₹1,158 Cr as of Jun 2026, so its debt is 0.70× its equity. Year by year, that ratio went from 0.64 in FY22 to 0.70 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Bodal Chemicals shareholding pattern? Foreign institutions raised their stake in Bodal Chemicals Ltd by 1.1 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 1.8% of the company. Domestic institutions moved +0.5 points over the same period, to 0.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +1.1 points over 8 quarters, to 1.8%; Domestic institutions: +0.5 points over 8 quarters, to 0.5%; Promoters: −0.3 points over 8 quarters, to 57.0%. Why the owners changed: foreign institutions drove it (+1.1 points), together with domestic institutions (+0.5 points). They raised their stake step by step. ## How far is Bodal Chemicals from balance-sheet trouble? For Bodal Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Bodal Chemicals rank in its industry? 68.9 out of 100, rank 2 of 10 in Dyes & Pigments, with 89% of the evidence available. Bodal Chemicals Ltd scores 68.9 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 2. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 24.5 + 10.1 + 14.3 + 20 = 68.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Bodal Chemicals compared with? Bodal Chemicals ranks 2 of 10 Dyes & Pigments companies on the 4-Factor Sector Score, with 68.9 out of 100. 1. [Bhageria Industries Ltd](https://www.sectoralpha.in/stocks/bhageria-industries-ltd) BHAGERIA · leader · Most evidence points up · 82% evidence 69.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 75.8% · Profit 100% · Operating margin change 8 points · 95% evidence Capital efficiency 14.3/25 · ROCE 9.4% · Operating margin 19% · 76% evidence Valuation 9.2/20 · P/E 14× · PEG n/a · 50% evidence Relative strength 17.7/20 · Lead over its industry 45.6% · Lead over NIFTY 500 79% · 1 year 61.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 28.5 + 14.3 + 9.2 + 17.7 = 69.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. Bodal Chemicals Ltd this page BODALCHEM · breaking out · Most evidence points up · 89% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.5/35 · Revenue 27.6% · Profit 100% · Operating margin change 0 points · 88% evidence Capital efficiency 10.1/25 · ROCE 5.6% · Operating margin 10% · 100% evidence Valuation 14.3/20 · P/E 30.2× · PEG 0.39 · 65% evidence Relative strength 20.0/20 · Lead over its industry 79.6% · Lead over NIFTY 500 114.4% · 1 year 168.5% · 100% evidence · 10 of 12 weeks ahead Exact sum: 24.5 + 10.1 + 14.3 + 20 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Atul Ltd](https://www.sectoralpha.in/stocks/atul-ltd) ATUL · quiet · Evidence leans up · 100% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.8/35 · Revenue 18.1% · Profit 40.5% · Operating margin change -4 points · 100% evidence Capital efficiency 19.3/25 · ROCE 14.9% · Operating margin 13% · 100% evidence Valuation 16.2/20 · P/E 19.2× · PEG 0.47 · 100% evidence Relative strength 0.0/20 · Lead over its industry -35.1% · Lead over NIFTY 500 -16.5% · 1 year -12.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.8 + 19.3 + 16.2 + 0 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Vidhi Specialty Food Ingredients Ltd](https://www.sectoralpha.in/stocks/vidhi-specialty-food-ingredients-ltd) VIDHIING · losing its lead · Evidence leans up · 85% evidence 55.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 34.4% · Profit 22.4% · Operating margin change -5 points · 100% evidence Capital efficiency 21.8/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 5.3/20 · P/E 25.5× · PEG 2.77 · 100% evidence Relative strength 9.3/20 · Lead over its industry n/a · Lead over NIFTY 500 1.3% · 1 year -9% · 25% evidence · 10 of 12 weeks ahead Exact sum: 18.8 + 21.8 + 5.3 + 9.3 = 55.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 5. [Ultramarine & Pigments Ltd](https://www.sectoralpha.in/stocks/ultramarine-pigments-ltd) ULTRAMAR · quiet · Evidence leans up · 81% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 15.6% · Profit 16.5% · Operating margin change 2 points · 88% evidence Capital efficiency 15.6/25 · ROCE 10.8% · Operating margin 19% · 100% evidence Valuation 9.6/20 · P/E 11.4× · PEG 2.42 · 100% evidence Relative strength 7.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -10.2% · 1 year -22.3% · 25% evidence · 7 of 12 weeks ahead Exact sum: 20.5 + 15.6 + 9.6 + 7.9 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Kiri Industries Ltd](https://www.sectoralpha.in/stocks/kiri-industries-ltd) KIRIINDUS · breaking out · Evidence leans down · 71% evidence 49.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 25% · Profit 100% · Operating margin change 13 points · 83% evidence Capital efficiency 5.3/25 · ROCE 3.4% · Operating margin 5% · 76% evidence Valuation 11.5/20 · P/E 4.4× · PEG n/a · 15% evidence Relative strength 12.3/20 · Lead over its industry -4.7% · Lead over NIFTY 500 21.4% · 1 year 1% · 100% evidence · 11 of 12 weeks ahead Exact sum: 20.7 + 5.3 + 11.5 + 12.3 = 49.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Sudarshan Colorants India Ltd](https://www.sectoralpha.in/stocks/sudarshan-colorants-india-ltd) SUDARCOLOR · turning · Evidence leans down · 100% evidence 47.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue 6.3% · Profit -9.8% · Operating margin change 3 points · 100% evidence Capital efficiency 11.9/25 · ROCE 11.4% · Operating margin 13% · 100% evidence Valuation 17.6/20 · P/E 14.5× · PEG 0.47 · 100% evidence Relative strength 6.7/20 · Lead over its industry -20.5% · Lead over NIFTY 500 2% · 1 year -28.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 11.2 + 11.9 + 17.6 + 6.7 = 47.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Sudarshan Chemical Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-chemical-industries-ltd) SUDARSCHEM · breaking out · Evidence leans down · 81% evidence 44.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.6/35 · Revenue 90.2% · Profit 2.3% · Operating margin change 2 points · 88% evidence Capital efficiency 8.4/25 · ROCE 5.5% · Operating margin 10% · 100% evidence Valuation 6.4/20 · P/E 78.1× · PEG 1.29 · 100% evidence Relative strength 11.1/20 · Lead over its industry n/a · Lead over NIFTY 500 5.5% · 1 year -13.7% · 25% evidence · 12 of 12 weeks ahead Exact sum: 18.6 + 8.4 + 6.4 + 11.1 = 44.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Sadhana Nitro Chem Ltd](https://www.sectoralpha.in/stocks/sadhana-nitro-chem-ltd) SADHNANIQ · quiet · Most evidence points down · 71% evidence 32.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.1/35 · Revenue -24.3% · Profit -80% · Operating margin change 646.8 points · 74% evidence Capital efficiency 4.0/25 · ROCE -11.1% · Operating margin 17.9% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 6.3/20 · Lead over its industry -16.2% · Lead over NIFTY 500 5% · 1 year 13.1% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.1 + 4 + 10 + 6.3 = 32.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Indokem Ltd](https://www.sectoralpha.in/stocks/indokem-ltd) INDOKEM · breaking out · Most evidence points down · 64% evidence 29.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.8/35 · Revenue -4.5% · Profit -57.5% · Operating margin change 0.5 points · 88% evidence Capital efficiency 3.1/25 · ROCE 5.5% · Operating margin 4.8% · 100% evidence Valuation 8.5/20 · P/E 799× · PEG n/a · 15% evidence Relative strength 11.4/20 · Lead over its industry n/a · Lead over NIFTY 500 8.2% · 1 year -7.2% · 25% evidence · 5 of 5 weeks ahead Exact sum: 6.8 + 3.1 + 8.5 + 11.4 = 29.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Dyes & Pigments](https://www.sectoralpha.in/sectors/dyes-pigments), all 10 compared on one page. ## Which companies are close to Bodal Chemicals in size? Bodal Chemicals is the 4th largest of 10 Dyes & Pigments companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Atul, Sudarshan Chemical Industries and Kiri Industries. Just below it: Indokem, Bhageria Industries and Vidhi Specialty Food Ingredients. ### Dyes & Pigments companies close in size

1. [Atul Ltd](https://www.sectoralpha.in/stocks/atul-ltd) ₹14,805 crore
2. [Sudarshan Chemical Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-chemical-industries-ltd) ₹7,930 crore
3. [Kiri Industries Ltd](https://www.sectoralpha.in/stocks/kiri-industries-ltd) ₹3,513 crore
4. Bodal Chemicals Ltd ₹2,072 crore
5. [Indokem Ltd](https://www.sectoralpha.in/stocks/indokem-ltd) ₹1,790 crore
6. [Bhageria Industries Ltd](https://www.sectoralpha.in/stocks/bhageria-industries-ltd) ₹1,582 crore
7. [Vidhi Specialty Food Ingredients Ltd](https://www.sectoralpha.in/stocks/vidhi-specialty-food-ingredients-ltd) ₹1,538 crore

[All 10 Dyes & Pigments companies, largest first](https://www.sectoralpha.in/sectors/dyes-pigments#all-companies)

### Companies close in size in other industries

1. [Pennar Industries Ltd](https://www.sectoralpha.in/stocks/pennar-industries-ltd) ₹2,090 crore · Pre-Engineering Buildings
2. [Zaggle Prepaid Ocean Services Ltd](https://www.sectoralpha.in/stocks/zaggle-prepaid-ocean-services-ltd) ₹2,073 crore · IT Product Companies
3. Bodal Chemicals Ltd ₹2,072 crore
4. [Mobavenue AI Tech Ltd](https://www.sectoralpha.in/stocks/mobavenue-ai-tech-ltd) ₹2,067 crore · Advertisement
5. [CFF Fluid Control Ltd](https://www.sectoralpha.in/stocks/cff-fluid-control-ltd) ₹2,059 crore · Shipping - Proxy

## What else do people ask about Bodal Chemicals? ### What is Bodal Chemicals's share price today? Bodal Chemicals Ltd's share price is ₹178.62, +191.2% over the past year. The whole company is worth ₹2,243 Cr on the market. In the last 52 weeks it traded between ₹43 to ₹202; today it is 85% of the way up from the low, 76.5% above its 200-day average (as of 3 November 2026). ### What were Bodal Chemicals's latest quarterly results? Bodal Chemicals Ltd reported revenue of ₹709 Cr and net profit of ₹30.0 Cr for the Jun 2026 quarter. Revenue rose 56.2% and profit rose 200.0% compared with a year earlier. Earnings per share were ₹2.41. The operating margin was 10.0%, 0.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Bodal Chemicals's market cap? Bodal Chemicals Ltd's market capitalisation is ₹2,243 Cr at a share price of ₹178.62. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Bodal Chemicals performing? Bodal Chemicals Ltd's share price has been rising for 26 weeks. In its latest quarter, revenue rose 56.2% and profit rose 200.0% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 13 weeks running (as of 3 November 2026). ### Will Bodal Chemicals's share price go up? This page does not forecast Bodal Chemicals Ltd's share price. What it shows instead: the share price is ₹178.62, and it has been rising for 26 weeks. Its P/E of 32.7× is higher than 83% of its own last 11 years (as of 3 November 2026). ### Who owns Bodal Chemicals? Promoters own 57.0% of Bodal Chemicals Ltd, foreign institutions 1.8%, domestic institutions 0.5% and the public 40.7% (latest quarter). The biggest change over the last two years: Foreign institutions raised their stake by 1.1 percentage points over 8 quarters (as of 3 November 2026). ### Does Bodal Chemicals have too much debt? Bodal Chemicals Ltd has a moderate amount of debt: its debt is 0.70× its equity, and its operating profit is 2 times its interest bill. FY26 borrowings were ₹813 Cr against equity of ₹1,157 Cr. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Bodal Chemicals in its business cycle? Bodal Chemicals Ltd's FY26 operating margin was 8.0%, against a 13-year range of 7.0% to 20.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 10.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Bodal Chemicals story? The main question: the share price moved +191.2% in a year while yearly earnings per share moved +158.5%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Bodal Chemicals a stock worth studying right now? What the numbers show: Bodal Chemicals Ltd's share price has risen faster than its earnings: +191.2% in a year, against +158.5% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.